Liu-Ying Yan

Combining stereotactic body radiotherapy with camrelizumab for unresectable hepatocellular carcinoma: a single-arm trial

T. Su, Shi-xiong Liang, J. Zhong, 2022, Hepatology International.

Combining stereotactic body radiotherapy with camrelizumab for unresectable hepatocellular carcinoma: a single-arm trial

T. Su, Shi-xiong Liang, J. Zhong, 2022, Hepatology International.

Prognostic value of a nomogram based on peripheral blood immune parameters in unresectable hepatocellular carcinoma after intensity-modulated radiotherapy

Shi-xiong Liang, J. Zhong, B. Xiang, 2022, BMC gastroenterology.

Non-classic radiation-induced liver disease after intensity-modulated radiotherapy for Child–Pugh grade B patients with locally advanced hepatocellular carcinoma

J. Zhong, B. Xiang, Jian-Xu Li, 2023, Radiation Oncology.

Radiotherapy plus anti-PD1 versus radiotherapy for hepatic toxicity in patients with hepatocellular carcinoma

B. Xiang, Hong-ping Yu, T. Su, 2023, Radiation Oncology.